Sakar Healthcare

{
  "main_header": {
    "sid": 1002668,
    "name": "Sakar Healthcare",
    "stock_name": "Sakar Healthcare",
    "full_name": "Sakar Healthcare Ltd",
    "name_url": "stocks-analysis/sakar-healthcare",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "463.75",
    "chg": -32.8,
    "chgp": "-6.61%",
    "dir": -1,
    "prev_price": "496.55",
    "mcapval": "1,110.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "SAKAR",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE732S01012",
    "curr_date": "Feb 10",
    "curr_time": "",
    "bse_nse_vol": 179384,
    "exc_status": "Active",
    "traded_date": "Feb 10, 2026",
    "traded_date_str": "2026 02 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sakar-healthcare-1002668-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Sakar Healthcare Surges 11.81%: 5 Key Developments Driving the Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcare-surges-1181-5-key-developments-driving-the-rally-3826100",
        "imagepath": "",
        "date": "2026-02-07 13:02:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Stock opens at ₹383.05, down 2.06% amid broader market weakness</p>\n                    <p><strong>3 Feb:</strong> Sharp rebound with 5.39% gain to ₹403.70, supported by technical momentum</p>\n                    <p><strong>4 Feb:</strong> Bullish momentum shift confirmed by technical indicators; stock closes at ₹409.80 (+1.51%)</p>\n                    <p><strong>5 Feb:</strong> Outstanding quarterly results propel stock 6.09% higher to ₹434.75</p>\n                    <p><strong>6 Feb:</strong> Continued bullish momentum lifts stock to ₹437.30 (+0.59%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><di..."
      },
      {
        "title": "Sakar Healthcare Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcare-ltd-technical-momentum-shifts-signal-bullish-outlook-3823685",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SakarHealthcare_technicaldot_3823685.png",
        "date": "2026-02-06 08:03:09",
        "description": "Sakar Healthcare Ltd has demonstrated a significant shift in price momentum, moving from a mildly bullish to a bullish technical trend, supported by a confluence of positive signals across key indicators such as MACD, RSI, moving averages, and Bollinger Bands. This technical upgrade accompanies a notable 6.09% gain in the stock price on 6 Feb 2026, reflecting renewed investor confidence in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Are Sakar Healthcare Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-sakar-healthcare-ltd-latest-results-good-or-bad-3822931",
        "imagepath": "",
        "date": "2026-02-05 19:29:44",
        "description": "Sakar Healthcare Ltd's latest financial results for the quarter ending December 2025 reflect a significant operational performance, characterized by robust growth in both revenue and net profit. The company reported a year-on-year revenue increase of 62.00%, reaching ₹70.34 crores, which notably surpasses its five-year sales growth rate of 16.59%. This acceleration indicates effective market penetration and possibly favorable industry dynamics.\n\nThe net profit for the same period surged by 126.27% year-on-year to ₹10.25 crores, showcasing strong profitability driven by improved operational efficiency and cost management. The operating margin, excluding other income, improved to 26.43%, marking a substantial enhancement from the previous quarter. This margin expansion is attributed to better operating leverage as revenue scaled, alongside controlled employee costs and reduced interest expenses.\n\nDespite thes..."
      },
      {
        "title": "Sakar Healthcare Ltd Reports Outstanding Quarterly Performance, Upgrades Financial Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcare-ltd-reports-outstanding-quarterly-performance-upgrades-financial-trend-3822628",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SakarHealthcare_fintrenddot_3822628.png",
        "date": "2026-02-05 15:00:20",
        "description": "Sakar Healthcare Ltd has delivered an exceptional quarterly performance for the December 2025 quarter, prompting an upgrade in its financial trend rating from positive to outstanding. The pharmaceutical and biotechnology company has demonstrated robust revenue growth, margin expansion, and improved capital efficiency, signalling a strong turnaround and enhanced investor confidence."
      },
      {
        "title": "Sakar Healthcare Q3 FY26: Stellar Profit Surge Masks Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/sakar-healthcare-q3-fy26-stellar-profit-surge-masks-valuation-concerns-3822561",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SakarHealthcare_quaterlyResult_3822561.png",
        "date": "2026-02-05 13:36:08",
        "description": "Sakar Healthcare Ltd., a Gujarat-based pharmaceutical manufacturer, delivered an exceptional third quarter performance for FY2026, with net profit more than doubling to ₹10.25 crores—a remarkable 125.77% quarter-on-quarter surge and 126.27% year-on-year growth. The micro-cap company, currently valued at ₹982.11 crores, saw its shares rally 7.71% following the results announcement, closing at ₹441.40 on February 5, 2026."
      },
      {
        "title": "Sakar Healthcare Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcare-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3821730",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SakarHealthcare_technicaldot_3821730.png",
        "date": "2026-02-05 08:04:23",
        "description": "Sakar Healthcare Ltd has exhibited a notable shift in its technical momentum, moving from a previously bearish stance to a mildly bullish outlook as of early February 2026. This transition is underscored by mixed signals from key technical indicators such as MACD, RSI, moving averages, and Bollinger Bands, reflecting a nuanced market sentiment amid the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Sakar Healthcare Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcare-ltd-sees-bullish-momentum-shift-amid-strong-technical-signals-3819799",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SakarHealthcare_technicaldot_3819799.png",
        "date": "2026-02-04 08:06:36",
        "description": "Sakar Healthcare Ltd has demonstrated a notable shift in price momentum and technical indicators, signalling a transition from a mildly bullish to a bullish trend. With a significant day gain of 5.39% and a recent upgrade in its Mojo Grade from Sell to Hold, the pharmaceutical and biotechnology company is attracting renewed investor interest amid improving technical signals and robust long-term returns."
      },
      {
        "title": "Sakar Healthcare Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sakar-healthcare-ltd-is-rated-hold-3817740",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SakarHealthcare_mojoScore_3817740.png",
        "date": "2026-02-03 10:14:03",
        "description": "Sakar Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 Sep 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 03 February 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Sakar Healthcare Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sakar-healthcare-ltd-technical-momentum-shifts-amid-mixed-market-signals-3804994",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SakarHealthcare_technicaldot_3804994.png",
        "date": "2026-01-27 08:03:01",
        "description": "Sakar Healthcare Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance, amid a complex interplay of technical indicators. Despite a recent decline in price, the stock’s monthly and weekly signals reveal a nuanced outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 384,
    "sid": "1002668",
    "stock_news_url": "https://www.marketsmojo.com/news/sakar-healthcare-1002668"
  },
  "announcements": [
    {
      "details": "Sakar Healthcare Limitedealthcare Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Sakar Healthcare Limited - Reply to Clarification- Financial results",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Sakar Healthcare Limitede Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Sakar Healthcare Limited - Clarification - Financial Results",
      "datetime": "03-Dec-2019"
    },
    {
      "details": "Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on November 14, 2019.",
      "source": "NSE",
      "caption": "Sakar Healthcare Limited - Outcome of Board Meeting",
      "datetime": "14-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sakar Healthcare Surges 11.81%: 5 Key Developments Driving the Rally

2026-02-07 13:02:02

Key Events This Week

2 Feb: Stock opens at ₹383.05, down 2.06% amid broader market weakness

3 Feb: Sharp rebound with 5.39% gain to ₹403.70, supported by technical momentum

4 Feb: Bullish momentum shift confirmed by technical indicators; stock closes at ₹409.80 (+1.51%)

5 Feb: Outstanding quarterly results propel stock 6.09% higher to ₹434.75

6 Feb: Continued bullish momentum lifts stock to ₹437.30 (+0.59%)

Read full news article

Sakar Healthcare Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-02-06 08:03:09

Sakar Healthcare Ltd has demonstrated a significant shift in price momentum, moving from a mildly bullish to a bullish technical trend, supported by a confluence of positive signals across key indicators such as MACD, RSI, moving averages, and Bollinger Bands. This technical upgrade accompanies a notable 6.09% gain in the stock price on 6 Feb 2026, reflecting renewed investor confidence in the Pharmaceuticals & Biotechnology sector.

Read full news article

Are Sakar Healthcare Ltd latest results good or bad?

2026-02-05 19:29:44

Sakar Healthcare Ltd's latest financial results for the quarter ending December 2025 reflect a significant operational performance, characterized by robust growth in both revenue and net profit. The company reported a year-on-year revenue increase of 62.00%, reaching ₹70.34 crores, which notably surpasses its five-year sales growth rate of 16.59%. This acceleration indicates effective market penetration and possibly favorable industry dynamics. The net profit for the same period surged by 126.27% year-on-year to ₹10.25 crores, showcasing strong profitability driven by improved operational efficiency and cost management. The operating margin, excluding other income, improved to 26.43%, marking a substantial enhancement from the previous quarter. This margin expansion is attributed to better operating leverage as revenue scaled, alongside controlled employee costs and reduced interest expenses. Despite thes...

Read full news article

Sakar Healthcare Ltd Reports Outstanding Quarterly Performance, Upgrades Financial Trend

2026-02-05 15:00:20

Sakar Healthcare Ltd has delivered an exceptional quarterly performance for the December 2025 quarter, prompting an upgrade in its financial trend rating from positive to outstanding. The pharmaceutical and biotechnology company has demonstrated robust revenue growth, margin expansion, and improved capital efficiency, signalling a strong turnaround and enhanced investor confidence.

Read full news article

Sakar Healthcare Q3 FY26: Stellar Profit Surge Masks Valuation Concerns

2026-02-05 13:36:08

Sakar Healthcare Ltd., a Gujarat-based pharmaceutical manufacturer, delivered an exceptional third quarter performance for FY2026, with net profit more than doubling to ₹10.25 crores—a remarkable 125.77% quarter-on-quarter surge and 126.27% year-on-year growth. The micro-cap company, currently valued at ₹982.11 crores, saw its shares rally 7.71% following the results announcement, closing at ₹441.40 on February 5, 2026.

Read full news article

Sakar Healthcare Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-02-05 08:04:23

Sakar Healthcare Ltd has exhibited a notable shift in its technical momentum, moving from a previously bearish stance to a mildly bullish outlook as of early February 2026. This transition is underscored by mixed signals from key technical indicators such as MACD, RSI, moving averages, and Bollinger Bands, reflecting a nuanced market sentiment amid the Pharmaceuticals & Biotechnology sector.

Read full news article

Sakar Healthcare Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals

2026-02-04 08:06:36

Sakar Healthcare Ltd has demonstrated a notable shift in price momentum and technical indicators, signalling a transition from a mildly bullish to a bullish trend. With a significant day gain of 5.39% and a recent upgrade in its Mojo Grade from Sell to Hold, the pharmaceutical and biotechnology company is attracting renewed investor interest amid improving technical signals and robust long-term returns.

Read full news article

Sakar Healthcare Ltd is Rated Hold

2026-02-03 10:14:03

Sakar Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 Sep 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 03 February 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Sakar Healthcare Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-01-27 08:03:01

Sakar Healthcare Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance, amid a complex interplay of technical indicators. Despite a recent decline in price, the stock’s monthly and weekly signals reveal a nuanced outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

View All News